{"id":22906,"date":"2017-03-15T16:01:24","date_gmt":"2017-03-15T16:01:24","guid":{"rendered":"https:\/\/corporate.webfactory.ferring.tech\/?p=22906"},"modified":"2021-05-10T18:12:50","modified_gmt":"2021-05-10T17:12:50","slug":"ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients","status":"publish","type":"post","link":"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/","title":{"rendered":"Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients"},"content":{"rendered":"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h2 style=\"color: #0088ce\">Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients<\/h2>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 style=\"color: #0088ce\">Saint-Prex, Switzerland \u201315 March 2017 \u2013<\/h3>\n<p>Ferring Pharmaceuticals and Brazil-based Instituto de Ci\u00eancias Farmac\u00eauticas (ICF) today announced a research collaboration aimed at developing a mucoadhesive rectal delivery system to treat anal fissures and to improve quality of care for patients with inflammatory bowel disease (IBD).<\/p>\n<p>Anal fissures are a common complication of inflammatory bowel disease (IBD). They can represent a challenging problem for patients with IBD but have been overlooked, with current treatments not sufficient to give long-lasting pain relief and promote healing.<sup><a href=\"#note1\" name=\"_ftnref1\">1<\/a><\/sup><\/p>\n<p>\u201cFerring is committed to enhancing the quality of life and quality of care of IBD patients through innovative scientific research,\u201d said Alan Harris, Senior Vice President R&D Executive Office, Ferring Pharmaceuticals. \u201cThis collaboration is focused on meeting a number of unmet needs – from alleviating the pain of anal fissures, to promoting faster healing, increasing patient adherence and developing more convenient dosing.\u201d<\/p>\n<p>\u201cOur collaboration also aims to address current unmet needs of physicians,\u201d said Leonardo Teixeira, CEO, ICF. \u201cWe want to develop a ready-to-use and patient-compliant delivery system with mucoadhesive properties, to provide doctors with an alternative to current topical treatments and surgical options.\u201d<\/p>\n<p>– ENDS –<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 style=\"color: #0088ce\">About Anal Fissure<\/h3>\n<p>Anal fissure is a tear in the lining of the lower rectum (anal canal) that causes pain during bowel movements. It is associated with constipation (due to the passage of bulky and hard stools), frequent bowel movement and diarrhoea, trauma in the anal area, diet poor in fibres and high in fat and fried foods, and in inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease. One cause of fissures is increased tension (called resting pressure) and spasm in the internal anal sphincter. Current treatments are not sufficient enough to give long-lasting pain relief and promote healing.<\/p>\n<h3 style=\"color: #0088ce\">About Ferring Pharmaceuticals<\/h3>\n<p>Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.<\/p>\n<p>To learn more about Ferring or its products please visit <a href=\"https:\/\/www.ferring.com\/\">www.ferring.com<\/a>.<\/p>\n<h3 style=\"color: #0088ce\">About ICF, Instituto de Ci\u00eancias Farmac\u00eauticas<\/h3>\n<p>ICF (Institute of Pharmaceutical Sciences) is a Brazil-based company dedicated to research and drug development in many disease areas. Active in over 30 countries, ICF has 15 years of experience and also focuses on Bioequivalence studies (BE) and in vitro analysis. ICF is a notable reference for industries and institutions from several countries.<\/p>\n<p>To learn more about ICF please visit <a href=\"http:\/\/www.icf.com\/\">www.icf.com<\/a>.<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 style=\"color: #0088ce\">For more information, please contact<\/h3>\n<p>Ferring Pharmaceuticals<br \/>\n<strong>Lindsey Rodger<\/strong><br \/>\n+41 58 451 40 23<br \/>\n<span class=\"antispam\"><a href=\"mailto:lindsey.rodger@ferring.com\">lindsey.rodger@ferring.com<\/a><\/span><\/p>\n<p>Instituto de Ci\u00eancias Farmac\u00eauticas\u00a0<strong><br \/>\nLaura Rezeck<\/strong><br \/>\n+55 62 3240 8700<br \/>\n<span class=\"antispam\"><a href=\"mailto:laura.rezeck@icf.com.br\">laura.rezeck@icf.com.br<\/a><\/span><\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 style=\"color: #0088ce\">References<\/h3>\n<ol>\n<li id=\"note1\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=D%27Ugo%20S%5BAuthor%5D&cauthor=true&cauthor_uid=26446683\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=es-419&q=https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term%3DD'Ugo%2520S%255BAuthor%255D%26cauthor%3Dtrue%26cauthor_uid%3D26446683&source=gmail&ust=1489595835775000&usg=AFQjCNHkZ_WDUB5Z4aav16-Q5gQjKIixAQ\">D’Ugo S<\/a>,\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Stasi%20E%5BAuthor%5D&cauthor=true&cauthor_uid=26446683\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=es-419&q=https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term%3DStasi%2520E%255BAuthor%255D%26cauthor%3Dtrue%26cauthor_uid%3D26446683&source=gmail&ust=1489595835775000&usg=AFQjCNGgcXjteB0jCi7xhK71j4CrAzxy8Q\">Stasi E<\/a>,\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Gaspari%20AL%5BAuthor%5D&cauthor=true&cauthor_uid=26446683\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=es-419&q=https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term%3DGaspari%2520AL%255BAuthor%255D%26cauthor%3Dtrue%26cauthor_uid%3D26446683&source=gmail&ust=1489595835775000&usg=AFQjCNE3yeq6W2APm9SgampPDMCNm5CBLg\">Gaspari AL<\/a>,\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Sileri%20P%5BAuthor%5D&cauthor=true&cauthor_uid=26446683\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=es-419&q=https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term%3DSileri%2520P%255BAuthor%255D%26cauthor%3Dtrue%26cauthor_uid%3D26446683&source=gmail&ust=1489595835775000&usg=AFQjCNFmvdKh1TDy-dS7Bp4tVLxj2lvG7Q\">Sileri P<\/a>. Hemorrhoids and anal fissures in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2015 Dec;61(4):223-33.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26446683\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?hl=es-419&q=https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26446683&source=gmail&ust=1489595835775000&usg=AFQjCNEt9WmIFZGI6ZutJ_bp0CAqTt0kIg\">PubMed.<\/a><\/li>\n<\/ol>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_row element_name=”Row” wrap_type=”content-width” parallax_image_height=”content-height” parallax_image_movement=”fixed” parallax_image_speed=”0.5″ bg_video_loop=”yes” parallax_video_height=”window-height” parallax_video_overlay=”none” row_overlay_opacity=”0″ row_col_pos=”default” minimize_row=”no” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_button button_text=”READ MORE PRESS RELEASES” button_size=”standard” button_colour=”accent” button_type=”standard” rounded=”no” button_dropshadow=”no” button_link=”\/media\/press-releases\/” button_target=”_self” align=”center” animation=”none” animation_delay=”0″ width=”1\/1″ el_position=”first last”] [\/spb_row]\n","protected":false},"excerpt":{"rendered":"<p>[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Saint-Prex, Switzerland \u201315 March 2017 \u2013 Ferring Pharmaceuticals and Brazil-based Instituto de Ci\u00eancias […]<\/p>\n","protected":false},"author":2410,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[244],"tags":[],"class_list":["post-22906","post","type-post","status-publish","format-standard","hentry","category-press-release-2017"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.3 (Yoast SEO v23.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients - Ferring Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients\" \/>\n<meta property=\"og:description\" content=\"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Saint-Prex, Switzerland \u201315 March 2017 \u2013 Ferring Pharmaceuticals and Brazil-based Instituto de Ci\u00eancias […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Ferring Global\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-15T16:01:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-10T17:12:50+00:00\" \/>\n<meta name=\"author\" content=\"pulse\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ferring\" \/>\n<meta name=\"twitter:site\" content=\"@ferring\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"pulse\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/\"},\"author\":{\"name\":\"pulse\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\"},\"headline\":\"Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients\",\"datePublished\":\"2017-03-15T16:01:24+00:00\",\"dateModified\":\"2021-05-10T17:12:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/\"},\"wordCount\":811,\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"articleSection\":[\"PRESS RELEASE 2017\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/\",\"url\":\"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/\",\"name\":\"Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients - Ferring Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/#website\"},\"datePublished\":\"2017-03-15T16:01:24+00:00\",\"dateModified\":\"2021-05-10T17:12:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ferring.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ferring.com\/#website\",\"url\":\"https:\/\/www.ferring.com\/\",\"name\":\"Ferring Pharmaceuticals\",\"description\":\"Helping people live better lives\",\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ferring.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ferring.com\/#organization\",\"name\":\"Ferring\",\"url\":\"https:\/\/www.ferring.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"contentUrl\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"width\":236,\"height\":154,\"caption\":\"Ferring\"},\"image\":{\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\",\"https:\/\/x.com\/ferring\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\",\"name\":\"pulse\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"caption\":\"pulse\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients - Ferring Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/","og_locale":"en_US","og_type":"article","og_title":"Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients","og_description":"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Saint-Prex, Switzerland \u201315 March 2017 \u2013 Ferring Pharmaceuticals and Brazil-based Instituto de Ci\u00eancias […]","og_url":"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/","og_site_name":"Ferring Global","article_publisher":"https:\/\/www.facebook.com\/ferringpharmaceuticals\/","article_published_time":"2017-03-15T16:01:24+00:00","article_modified_time":"2021-05-10T17:12:50+00:00","author":"pulse","twitter_card":"summary_large_image","twitter_creator":"@ferring","twitter_site":"@ferring","twitter_misc":{"Written by":"pulse","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/#article","isPartOf":{"@id":"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/"},"author":{"name":"pulse","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d"},"headline":"Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients","datePublished":"2017-03-15T16:01:24+00:00","dateModified":"2021-05-10T17:12:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/"},"wordCount":811,"publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"articleSection":["PRESS RELEASE 2017"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/","url":"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/","name":"Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients - Ferring Global","isPartOf":{"@id":"https:\/\/www.ferring.com\/#website"},"datePublished":"2017-03-15T16:01:24+00:00","dateModified":"2021-05-10T17:12:50+00:00","breadcrumb":{"@id":"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ferring.com\/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ferring.com\/"},{"@type":"ListItem","position":2,"name":"Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients"}]},{"@type":"WebSite","@id":"https:\/\/www.ferring.com\/#website","url":"https:\/\/www.ferring.com\/","name":"Ferring Pharmaceuticals","description":"Helping people live better lives","publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ferring.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ferring.com\/#organization","name":"Ferring","url":"https:\/\/www.ferring.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/","url":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","contentUrl":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","width":236,"height":154,"caption":"Ferring"},"image":{"@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ferringpharmaceuticals\/","https:\/\/x.com\/ferring"]},{"@type":"Person","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d","name":"pulse","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","caption":"pulse"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22906"}],"collection":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/users\/2410"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/comments?post=22906"}],"version-history":[{"count":0,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22906\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/media?parent=22906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/categories?post=22906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/tags?post=22906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}